HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Recombinant human erythropoietin use in hemolytic anemia due to prosthetic heart valves: a promising treatment.

Abstract
Two patients are reported with hemolytic anemia due to red blood cell fragmentation in association with prosthetic heart vales. They were treated with erythropoietin which eliminated the need for packed red blood cell transfusion.
AuthorsS Hirawat, S M Lichtman, S L Allen
JournalAmerican journal of hematology (Am J Hematol) Vol. 66 Issue 3 Pg. 224-6 (Mar 2001) ISSN: 0361-8609 [Print] United States
PMID11279631 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Hemoglobins
  • Recombinant Proteins
  • Erythropoietin
Topics
  • Aged
  • Anemia, Hemolytic (blood, drug therapy, etiology)
  • Erythropoietin (therapeutic use)
  • Female
  • Heart Valve Prosthesis (adverse effects)
  • Hematocrit
  • Hemoglobins (analysis)
  • Humans
  • Male
  • Mitral Valve
  • Recombinant Proteins
  • Reticulocyte Count

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: